All News

Endocrine Month in Review: April 2021

April 24, 2021

April's month in review features stories related to new diabetes medications, stem cells, disparities in care of women, and how exposure to endocrine-disrupting chemicals in pregnancy can impact mental health following delivery. Check back in during the last weekend of each month for the next Endocrine Month in Review.

ACC/AHA 2017 Exercise Recommendations May Not Be Enough to Prevent Hypertension

April 19, 2021

An analysis of the CARDIA study by investigators at UCSF suggests a recommendation of 5 hours of physical activity per week may be more appropriate than the current ACC/AHA recommendation for reducing the risk of hypertension.

Race, Gender, & Income Influence Access to SGLT2 Inhibitors Among US Patients

April 15, 2021

Using data from nearly 1 million patients with type 2 diabetes in a commercial database, investigators provide a comprehensive of the impact race/ethnicity, gender, and income can have on the likelihood of receiving a prescription for SGLT2 inhibitors.